Blonanserin

Suppliers

Names

[ Name ]:
Blonanserin

[Synonym ]:
2-(4-Ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine
2-(4-ethylpiperazin-1-yl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydrocycloocta[b]pyridine
Lonasen
Blonanserin
Cycloocta[b]pyridine, 2-(4-ethyl-1-piperazinyl)-4-(4-fluorophenyl)-5,6,7,8,9,10-hexahydro-

Chemical & Physical Properties

[ Density]:
1.1±0.1 g/cm3

[ Boiling Point ]:
540.8±50.0 °C at 760 mmHg

[ Melting Point ]:
117-119°C

[ Molecular Formula ]:
C₂₃H₃₀FN₃

[ Molecular Weight ]:
367.503

[ Flash Point ]:
280.9±30.1 °C

[ Exact Mass ]:
367.242371

[ PSA ]:
19.37000

[ LogP ]:
6.03

[ Appearance of Characters ]:
white to off-white

[ Vapour Pressure ]:
0.0±1.4 mmHg at 25°C

[ Index of Refraction ]:
1.557

[ Storage condition ]:
Refrigerator

[ Water Solubility ]:
DMSO: ≥10mg/mL

MSDS

Click to get detail MSDS

Safety Information

[ Symbol ]:

GHS07

[ Signal Word ]:
Warning

[ Hazard Statements ]:
H302-H413

[ Hazard Codes ]:
Xn

[ Risk Phrases ]:
22

[ RIDADR ]:
NONH for all modes of transport

[ RTECS ]:
GY0175140

Articles

Asenapine, blonanserin, iloperidone, lurasidone, and sertindole: distinctive clinical characteristics of 5 novel atypical antipsychotics.

Clin. Neuropharmacol. 36(6) , 223-38, (2013)

Schizophrenia is a serious, chronic, and devastating mental illness with a substantial impact on psychological, physical, social, and economical areas of an individual and society. To treat such criti...

Blonanserin in the treatment of delirium.

Psychiatry Clin. Neurosci. 65(4) , 389-91, (2011)

The purpose of the present study was to provide preliminary data on the usefulness and safety of blonanserin for patients with delirium in the intensive care unit (ICU). The charts of 32 consecutive p...

Five Alzheimer's disease cases with refractory behavioural psychological symptoms of dementia treated with blonanserin.

Psychogeriatrics 10(4) , 198-200, (2010)

The aim of the present study was to determine the efficacy, side-effects and tolerability of blonanserin for treating refractory behavioural psychological symptoms of dementia (BPSD). The present stud...

Blonanserin C
Blonanserin N-Oxide
Blonanserin Impurity 10
Blonanserin dihydrochloride
5-Bromo-2-fluoro-3-(trifluoromethyl)phenylacetonitrile
2-Bromo-5-fluoro-4-(trifluoromethyl)phenylacetonitrile
4-(Piperidin-4-yl)pentanenitrile
5-amino-1-(1-benzylpiperidin-4-yl)-4-(4-methyl-1,3-thiazol-2-yl)-1,2-dihydro-3H-pyrrol-3-one
Benzamide, 2-bromo-4-formyl-
(R)-2-(4-(Trifluoromethoxy)phenyl)azetidine
5-amino-4-[4-(4-chlorophenyl)-1,3-thiazol-2-yl]-1-isobutyl-1,2-dihydro-3H-pyrrol-3-one
6-bromo-3-fluoro-2-methyl-2H-indazol-4-ol
(3S)-3-Amino-3-(6-bromo(2H-benzo[3,4-D]1,3-dioxolen-5-YL))propan-1-OL
5-amino-4-(4,5-dimethyl-1,3-thiazol-2-yl)-1-(3-hydroxypropyl)-1,2-dihydro-3H-pyrrol-3-one

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.